Targeting IL-17 and TH17 cells in chronic inflammation
The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Abstract
The key role of interleukin-17 (IL-17) and T helper 17 (T(H)17) cells in tissue inflammation, autoimmunity and host defence led to the experimental targeting of these molecules in mouse models of diseases as well as in clinical settings. Moreover, the demonstration that IL-17 and T(H)17 cells contribute to local and systemic aspects of disease pathogenesis, as well as the finding that the IL-17-T(H)17 cell pathway is regulated by IL-23, prompted the identification of inhibitors. These inhibitors include biotechnology products that target IL-23 as well as the leading member of the IL-17 family, IL-17A, and one of its receptors, IL-17 receptor A. Several clinical trials of these inhibitors are underway, and positive results have been obtained in psoriasis, rheumatoid arthritis and ankylosing spondylitis. This Review focuses on the current knowledge of the IL-17-T(H)17 cell pathway to better understand the positive as well as potential negative consequences of targeting them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Abs against IL-17/IL-17RA are in clinical trials for other autoimmune conditions [55].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [55]
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Research works printed but not linked: 1
- Baeten, D. et al. The anti-IL17A monoclonal antibody secukinumab (AIN457) showed good safety and efficacy in the treatment of active ankylosing spondylitis. Arthritis Rheum. 62, Abstract L3847 (2010).
Cited by
Items 701–800 of 1,000
Hernández, D. M. P., Gómez, J. A., Lorenzo, N., Corrales, O., López, A. C. A., Dalmau, E. G., Cabrales, A., Reyes, Y., Bermudez, Y., Avila, Y., et al. (2018) · Journal of Clinical Trials · doi:10.4172/2167-0870.1000339 · Cited by 22
“In addition, IL-17 increases the production of matrix metalloproteinase and nitric oxide in chondrocytes and osteoblasts, which lead to degradation of cartilage and bone [39].”
BackgroundThymic Program Directing the Functional Development of γδT17 Cells
Jouan, Y., Patin, E. C., Hassane, M., Si‐Tahar, M., Baranek, T., & Paget, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00981 · Cited by 19
“Recent evidence indicates that IL-17 also emerges as a key contributor in immunity beyond the scope of infection, such as inflammation and cancer (3, 4).”
BackgroundDiscovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists
Sun, N., Huang, Y., Yu, M., Zhao, Y., Chen, J., Zhu, C., Song, M., Guo, H., Xie, Q., & Wang, Y. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112536 · Cited by 20
IL-17F Gene rs763780 and IL-17A rs2275913 Polymorphisms in Patients with Periodontitis
Mazurek−Mochol, M., Kozak, M., Malinowski, D., Safranow, K., & Pawlik, A. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18031081 · Cited by 21
Yang, Y., Chen, Y., Yu, L., Zhang, X., Shang, J., Fan, J., Zhang, R., Ren, J., & Duan, X. (2022) · Inflammation Research · doi:10.1007/s00011-022-01674-z · Cited by 21
“However, Schmidt et al. showed opposite results in the absence of studies in lupus-prone mice, where their use of IL-17A inhibitors and knockdown of the IL-17 gene did not improve survival, glomerulonephritis, or autoantibody levels in mice [76].”
BackgroundInfluentialNoack, M., Ndongo-Thiam, N., & Miossec, P. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00509 · Cited by 21
“In our in vitro system, Tocilizumab decreased significantly IL-1β and IL-17 secretion (26, 31, 32).”
BackgroundSelf-citationΜaione, F., Iqbal, A. J., Raucci, F., Letek, M., Bauer, M., & D’Acquisto, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02752 · Cited by 21
Never say yes to parabens? A review on paraben compounds in potential human exposure risks
Haldar, S., Mukherjee, S., & Dey, A. (2025) · The Journal of Basic and Applied Zoology · doi:10.1186/s41936-025-00430-z · Cited by 20
“…orphan receptor is a ligand-dependent nuclear receptor that regulates the immune response and upon disruption of its function, it can cause enhanced inflammation in autoimmune diseases like rheumatoid arthritis, Crohn’s disease, psoriasis, and multiple sclerosis (Miossec & Kolls, 2012).”
At The Interface: Small-Molecule Inhibitors of Soluble Cytokines
Raavi, Koehler, A. N., & Vegas, A. J. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00469 · Cited by 19
Xiong, H., Luo, M., Ju, Y., Zhao, Z., Zhang, M., Xu, R., Ren, Y., Yang, G., & Mei, Z. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113707 · Cited by 18
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis
Chiricozzi, A., Costanzo, A., Fargnoli, M. C., Malagoli, P., Piaserico, S., Amerio, P., Argenziano, G., Balato, N., Bardazzi, F., Bianchi, L., et al. (2021) · European Journal of Dermatology · doi:10.1684/ejd.2021.3965 · Cited by 19
Auto-immunity and the gut microbiome in type 1 diabetes: Lessons from rodent and human studies
Snethlage, C. M. F., Nieuwdorp, M., van Raalte, D. H., Rampanelli, E., Verchere, C. B., & Hanssen, N. M. J. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101544 · Cited by 21
Splenic Denervation Attenuates Repeated Social Defeat Stress-Induced T Lymphocyte Inflammation
Elkhatib, S. K., Moshfegh, C. M., Watson, G. F., Schwab, A. D., Katsurada, K., Patel, K. P., & Case, A. J. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.05.004 · Cited by 22
Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases
da Silva, E. M., Yariwake, V. Y., Alves, R. W., de Araújo, D. R., & Andrade‐Oliveira, V. (2022) · Peptides · doi:10.1016/j.peptides.2022.170834 · Cited by 18
Nagafuchi, Y., Ota, M., Hatano, H., Inoue, M., Kobayashi, S., Okubo, M., Sugimori, Y., Nakano, M., Yamada, S., Yoshida, R., et al. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102907 · Cited by 18
Cao, L., Deng, J., Chen, W., He, M., Zhao, N., Huang, H., Ling, L., Li, Q., Zhu, X., & Wang, L. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168384 · Cited by 20
“Th17 cells categorized as pathogenic or nonpathogenic subtypes, depending on the cytokine milieu, display considerable plasticity (4).”
Li, Y., Yao, G., Wang, R., Zhu, J., Li, H., Yang, D., Ma, S., Fu, Y., Liu, C., & Guan, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111308 · Cited by 19
Pandit, H., Thakur, G., Gopalakrishnan, A. R. K., Dodagatta-Marri, E., Patil, A. D., Kishore, U., & Madan, T. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.10.004 · Cited by 18
Distinctive expression of interleukin‐23 receptor subunits on human Th17 and γδ T cells
Wines, B. D., Yap, M. L., Powell, M. S., Tan, P. S., Ko, K. K., Orlowski, E., & Hogarth, P. M. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.93 · Cited by 20
Epitope‐Targeted Macrocyclic Peptide Ligand with Picomolar Cooperative Binding to Interleukin‐17F
Lai, B. T., Wilson, J. A., Loredo, J. M., Pitram, S. M., LaBerge, N. A., Heath, J. R., & Agnew, H. D. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201704752 · Cited by 20
Expression of Th17/Treg related molecules in gastric cancer tissues
Meng, X., Zhu, S., Dong, Q., Zhang, S., Ma, J., & Zhou, C. (2018) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2018.17114 · Cited by 19
“The pathogenic role of IL-17 and IL-6 in malignancies may be mediated by stimulating the inflammatory cells, such as neutrophils, macrophages, fibroblasts, and endothelial cells, inducing angiogenesis and activating the small signaling G proteins -Rho protein (11,19,24-26).”
BackgroundIL-20-Receptor Signaling Delimits IL-17 Production in Psoriatic Inflammation
Ha, H., Wang, H., Claudio, E., Tang, W., & Siebenlist, U. K. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.06.127 · Cited by 19
IL-23/IL-17 INHIBITORS IN IMMUNOINFLAMMATORY RHEUMATIC DISEASES: NEW HORIZONS
Nasonov, E. L., Korotaeva, T. V., Дубинина, Т. В., & Lila, A. M. (2019) · Rheumatology Science and Practice · doi:10.14412/1995-4484-2019-400-406 · Cited by 25
Zhuang, Y., Chen, Y., Zhou, S., Hu, P., Chen, Y., & Li, D. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01451-y · Cited by 18
“IL-17 is a major proinflammatory cytokine secreted by activated T helper 17 (Th17) and contributes to the pathogenesis of both infectious and inflammatory diseases [51].”
BackgroundZheng, S., Shen, F., Jones, B. H., Fink, D., Geist, B. J., Nnane, I. P., Zhou, Z., Hall, J., Malaviya, R., Ort, T., et al. (2020) · mAbs · doi:10.1080/19420862.2020.1770018 · Cited by 18
“IL-17A homodimer binds to heterodimeric receptor complex consisting of IL-17RA and IL17RC and drives expression of cytokines and chemokines, recruitment and activation of leukocytes, and tissue damage.(15) A rapidly growing body of literature suggests that IL-17A promotes the chronic inflammation underlying the pathop…”
BackgroundMa, S., Qian, C., Li, N., Fang, Z., Zhao, J., Zhang, H., Chen, W., Liu, Z., & Lu, W. (2021) · Food Science & Nutrition · doi:10.1002/fsn3.1914 · Cited by 18
“The early stages of this dynamic process F I G U R E 6 Linear effect size comparison between the model group and other groups (p < .05, LDA score (log10) >2.0) are characterized by neutrophilic activity (Miossec & Kolls, 2012), the degree of which can be characterized by the level of MPO activity.”
BackgroundInfluentialOrthosteric and Allosteric Dual Targeting of the Nuclear Receptor RORγt with a Bitopic Ligand
Meijer, F. A., Oerlemans, G. J. M., & Brunsveld, L. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00941 · Cited by 20
Jiang, Y., Yang, M., Zhang, Y., Huang, Y., Wu, J., Xie, Y., Wei, Q., Liao, Z., & Gu, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.738316 · Cited by 20
“IL-17A, expressed by Th17 cells and multiple lineages of the innate immune system, can act as a chemokine directly on immune cells, thus bridging innate and adaptive immunity (Gaffen, 2009; Miossec and Kolls, 2012).”
BackgroundInfluence of Gestational Hormones on the Bacteria‐Induced Cytokine Response in Periodontitis
Ortiz‐Sánchez, B. J., Legorreta‐Herrera, M., & Rodríguez‐Sosa, M. (2021) · Mediators of Inflammation · doi:10.1155/2021/5834608 · Cited by 22
“IL-17 can enhance RANKL expression on osteoblasts by promoting the secretion of MMP-1, MMP3, IL-6, and IL-8 from gingival fibroblasts and TNF release from macrophages in periodontal tissues [42] and activate RANK signalling on osteoclasts, promoting osteoclastogenesis [43].”
What Have Failed, Interrupted, and Withdrawn Antibody Therapies in Multiple Sclerosis Taught Us?
Krämer, J., & Wiendl, H. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01246-3 · Cited by 18
“Thus, IL-17A stimulates different cell types including fibroblasts, endothelial and epithelial cells to produce proinflammatory mediators which lead to an overall leukocyte activation, tissue inflammation, and destruction [87, 88, 91].”
BackgroundSun, W., Yang, Z.-N., Lin, H., Liu, M., Zhao, C., Hou, X., Hu, Z., & Cui, B. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.02.007 · Cited by 19
Bhat, T. A., Kalathil, S. G., Bogner, P. N., Lehmann, P., Thatcher, T. H., Sime, P. J., & Thanavala, Y. M. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001228 · Cited by 18
Reda, G., Noto, A., Cassin, R., Zamprogna, G., Borella, C., Scarfò, L., Farina, L., Molteni, A., Ghia, P., Tedeschi, A., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0966-y · Cited by 18
Peng, Y., Deng, X., Xu, Z., Wu, Z., & Fu, Q. (2023) · European Journal of Immunology · doi:10.1002/eji.202149510 · Cited by 18
“IL-17 has also been reported to contribute to AD [38].”
BackgroundGut microbiota-mediated IL-22 alleviates metabolic inflammation
Wang, K., Zhou, M., Si, H., & Ma, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122229 · Cited by 19
Jia, R., Zheng, H., Li, S., Chen, W., Yang, Y., Wu, H., Chen, H., Qin, S., & Huang, S. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155779 · Cited by 17
Audu, C. O., Wolf, S., Joshi, A., Moon, J. Y., Melvin, W. J., Sharma, S. B., Davis, F. M., Obi, A. T., Wasikowski, R., Tsoi, L. C., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.172959 · Cited by 18
Biomarkers in the Clinical Development of Asthma Therapies
Staton, T. L., Choy, D. F., & Arron, J. R. (2016) · Biomarkers in Medicine · doi:10.2217/bmm.15.116 · Cited by 18
Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
Cerullo, V., Capasso, C., Vähä-Koskela, M. J. V., Hemminki, O., & Hemminki, A. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009617666170502152352 · Cited by 18
Anti-psoriasis effect of water-processed rosin in mice
Li, X. Q., Chen, Y., Zhou, H., Shi, H. L., Yan, X., Lin, L., & Tan, R. X. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112073 · Cited by 17
Interleukin‐17A affects extracellular vesicles release and cargo in human keratinocytes
Mangino, G., Iuliano, M., Carlomagno, S., Bernardini, N., Rosa, P., Chiantore, M. V., Skroza, N., Calogero, A., Potenza, C., & Romeo, G. (2019) · Experimental Dermatology · doi:10.1111/exd.14015 · Cited by 17
Li, C., Chen, L., Wang, L.-F., Yan, B., Liang, Y., & Luo, J. (2020) · International Journal of Ophthalmology · doi:10.18240/ijo.2020.04.19 · Cited by 18
Yue, H., Gu, J. F., Zhao, X., Liang, W., & Wu, Z. (2021) · Archives of Medical Science · doi:10.5114/aoms/130392 · Cited by 17
“IL-17A and IL-17F are 50% homologous and can form either homologous dimers or heterodimers that bind to IL-17RA/IL-17RC, which can activate downstream nuclear factor kB (NF-kB) and mitogen-activated protein kinase (MAPK) signaling pathways by acting on signaling complex IL-17R-ACT1-TRAF6 [14].”
BackgroundMeijer, F. A., Saris, A., Doveston, R. G., Oerlemans, G. J. M., de Vries, R. M. J. M., Somsen, B. A., Unger, A., Klebl, B., Ottmann, C., Cossar, P. J., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00475 · Cited by 18
Murine cytomegalovirus promotes renal allograft inflammation via Th1/17 cells and IL-17A
Dhital, R., Anand, S., Graber, B., Zeng, Q., Velazquez, V. M., Boddeda, S. R., Fitch, J., Minz, R. W., Minz, M., Sharma, A., et al. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17116 · Cited by 17
Emerging roles of the Th17/IL-17-axis in glomerulonephritis
Ramani, K., & Biswas, P. S. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.029 · Cited by 17
Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats
Yan, J., Yang, X., Han, D. K., & Feng, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5431 · Cited by 18
“In an earlier phase II clinical trial, following treatment with secukinumab, an antibody that neutralizes IL‑17, MS patients displayed fewer new CNS lesions observed using magnetic resonance imaging, and lower annualized recurrence rates, compared with placebo‑treated patients (56).”
Interleukin-17F Has Anti-Tumor Effects in Oral Tongue Cancer
Almahmoudi, R., Salem, A., Murshid, S. A., Dourado, M. R., Apu, E. H., Salo, T. A., & Al‐Samadi, A. (2019) · Cancers · doi:10.3390/cancers11050650 · Cited by 17
“, psoriasis and arthritis) implies that translating these in vitro findings into future therapies is feasible [41].”
BackgroundPușcaș, A. D., Catana, A. M., Pușcaș, C., Roman, I., Vornicescu, C., Şomlea, M., & Orăsan, R. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7624 · Cited by 24
Implications of VIP and PACAP in Parkinson’s Disease: What do we Know So Far?
Resende, F., Ribeiro, F. M., & Lima, P. M. D. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200320162436 · Cited by 17
The role of interleukin-17 in the pathogenesis of systemic sclerosis: Pro-fibrotic or anti-fibrotic?
Bellando-Randone, S., Della‐Torre, E., & Balanescu, A. R. (2021) · Journal of Scleroderma and Related Disorders · doi:10.1177/23971983211039421 · Cited by 19
Transcriptional Profiling of Early and Late Phases of Bovine Tuberculosis
Abdelaal, H. F. M., Thacker, T. C., Wadie, B., Palmer, M. V., & Talaat, A. M. (2021) · Infection and Immunity · doi:10.1128/iai.00313-21 · Cited by 20
“For example, homologs of MPO, CTSG network (63, 64) imply that the IL-17 signaling pathway is activated through NF-kappa B axis (65, 66), indicating the tissue modeling following lung injury (67) and the IL-17 cytokine release resulted in priming of macrophage, fibroblast, or even T-cells (64, 68).”
BackgroundInfluentialKhalid, F., Takagi, K., Sato, A., Yamaguchi, M., Guestini, F., Miki, Y., Miyashita, M., Hirakawa, H., Ohi, Y., Rai, Y., et al. (2023) · Breast Cancer · doi:10.1007/s12282-023-01467-0 · Cited by 17
Lee, K., Lai, T., Lee, W.-J., Chen, Y.-C., Ho, K., Hung, W.-Y., Yang, Y., Chan, M., Hsieh, F.-K., Chung, C., et al. (2023) · Cancers · doi:10.3390/cancers15133288 · Cited by 17
“IL-17A targets various cells which contain its receptor, composed of IL-17RA and IL-17RC dimers, which results in host defense, chronic inflammation, tissue destruction and repair, and oncogenesis [6,7].”
BackgroundChang, Y.-H., Hsing, C., Chiu, C.-J., Wu, Y., Hsu, S., & Hsu, Y. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02952-1 · Cited by 18
“Therefore, IL-17A is critical for host defense against microbes because it promotes the recruitment of neutrophils and induces the production of antimicrobial peptides [20–22].”
BackgroundNaghib, S. M., Ahmadi, B., & Mozafari, M. R. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673286052240426044945 · Cited by 21
Wang, H., Han, S., Xie, J., Zhao, R., Li, S., & Li, J. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114863 · Cited by 17
Th17 cells in cancer: plasticity‐driven immunopathology and therapeutic opportunity
Sutanto, H., Ningtyas, M. C., Rachma, B., Pratiwi, L., & Fetarayani, D. (2025) · Immunology and Cell Biology · doi:10.1111/imcb.70043 · Cited by 21
CD4 aptamer–RORγt shRNA chimera inhibits IL-17 synthesis by human CD4+ T cells
Song, P., Chou, Y. K., Zhang, X., Meza‐Romero, R., Yomogida, K., Benedek, G., & Chu, C. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.037 · Cited by 19
“Increasing evidence indicates that Th17 cells and their released cytokines play a critical role in the pathogenesis of autoimmune and inflammatory diseases [16].”
BackgroundGαq controls rheumatoid arthritis via regulation of Th17 differentiation
Liu, Y., Wang, D., Li, F., & Shi, G. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.13 · Cited by 16
Treatment of spondyloarthropathy
Her, M., & Kavanaugh, A. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283620177 · Cited by 16
Targeting calpains: A novel immunomodulatory approach for microbial infections
Kumar, V., & Ahmad, A. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.002 · Cited by 19
Samtsov, A. V., Khairutdinov, V. R., Bakulev, A. L., Kubanov, A. A., Karamova, A. Е., Artemeva, A. V., & Korotaeva, T. V. (2017) · Vestnik dermatologii i venerologii · doi:10.25208/0042-4609-2017-93-5-52-63 · Cited by 22
Khatri, A., & Othman, M. I. A. (2018) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1068 · Cited by 17
The expression and clinical significance of serum IL-17 in patients with primary biliary cirrhosis
Sun, Q., Wang, Q., Ning, F., Meng, Y., Li, B., Luo, D., Shang, X., Lv, J., Monsaf, A. M., Wang, C., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.07.100 · Cited by 16
“It plays an important role in autoimmune diseases by promoting the secretion, release and chemotaxis of various inflammatory factors to the site of inflammation and synergizing with them to amplify biological effects (25,26).”
BackgroundA Novel TRAF3IP2 Mutation Causing Chronic Mucocutaneous Candidiasis
Marujo, F., Pelham, S. J., Freixo, J. P., Cordeiro, A. I., Martins, C. G., Casanova, J., Lei, W., Puel, A., & Neves, J. F. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-01026-2 · Cited by 16
“albicans infections has been demonstrated following the identification of AD IL-17F or JNK1 deficiency or AR IL-17RA, IL-17RC, or ACT1 deficiencies, in patients with CMC [1, 6].”
BackgroundPai, F.-T., Lu, C., Lin, C., Wang, J., Huang, M., Liu, C.-T., Song, Y., Ku, C., & Yen, H. (2021) · Life · doi:10.3390/life11060587 · Cited by 16
Activation of retinoic acid-related orphan receptor γ(t) by parabens and benzophenone UV-filters
Inderbinen, S. G., Kley, M., Zogg, M., Sellner, M. S., Fischer, A., Kędzierski, J., Boudon, S. M., Jetten, A. M., Smieško, M., & Odermatt, A. (2022) · Toxicology · doi:10.1016/j.tox.2022.153159 · Cited by 19
“…T helper 17 cells (Th17) and innate lymphoid cells 3 (ILC3) (Ivanov et al., 2006; Montaldo et al., 2015), and was found to be associated with enhanced inflammation in autoimmune disorders, such as psoriasis, rheumatoid arthritis, multiple sclerosis and Crohn’s disease (Miossec and Kolls, 2012).”
BackgroundShan, C., Ji, X., Wu, Z., & Zhao, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-12366-3 · Cited by 16
Ponde, N. O., Shoger, K. E., Khatun, M. S., Sarkar, M. K., Dey, I., Taylor, T. C., Cisney, R. N., Arunkumar, S. P., Gudjonsson, J. E., Kolls, J. K., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300110 · Cited by 17
Self-citationWang, H., Zhao, J., Zhang, H., Huang, Y., Wang, S., Tu, Q., & Yang, N. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12275 · Cited by 16
n-3 Polyunsaturated fatty acids and mast cell activation
Wang, X., & Kulka, M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ru0814-388r · Cited by 18
“IL-17 Human [82] Promotes tissue remodeling and production of proinflammatory cytokines [83] Unknown”
BackgroundNdongo-Thiam, N., Clement, A., Pin, J., Razanajaona, D., & Miossec, P. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209149 · Cited by 17
Self-citationKajikawa, T., Meshikhes, F., Maekawa, T., Hajishengallis, E., Hosur, K. B., Abe, T., MOSS, K. L., Chavakis, T., & Hajishengallis, G. (2017) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12707 · Cited by 16
Valenzuela, F., de la Cruz, C., Galimberti, R., Gürbüz, S., McKean-Matthews, M., Goncalves, L., & Romiti, R. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2017.02.005 · Cited by 17
Guan, X., Lu, Y., Wang, G., Gibson, P. G., Chen, F., Fang, K., Wang, Z., Pang, Z., Guo, Y., Lu, J., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/8387150 · Cited by 18
“IL-17, as an important mediator in promoting tissue inflammation, could upregulate proinflammatory cytokines and chemokines [43].”
BackgroundCarnt, N. A., Cipriani, V., Stapleton, F. J., Calder, V. L., & Willcox, M. D. P. (2019) · Contact Lens and Anterior Eye · doi:10.1016/j.clae.2019.06.007 · Cited by 16
Ahmed, L. A., Mohamed, A. F., El-Haleim, E. A. A., & El-Tanbouly, D. M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.651150 · Cited by 18
“…expressing ROR-γt have pivotal roles in tissue inflammation and autoimmunity by releasing IL-17 (Crome et al., 2010; Hammerich et al., 2011; Miossec and Kolls, 2012), while Tregs phenotypes expressing FoxP3 exert an anti-inflammatory Frontiers in Pharmacology | www.frontiersin.org April…”
BackgroundTotal glucosides of paeony prevents juxta-articular bone loss in experimental arthritis
Chen, W., You, F. T., Mei, L. Y., Jian, S., & Qiang, C. Y. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-186 · Cited by 16
“IL-17 is produced mainly by pro-inflammatory T-helper subset (Th17) cells and both IL-17 and Th17 cells are deeply implicated with the pathogenesis of RA [37].”
BackgroundInvolvement of RORγt-overexpressing T cells in the development of autoimmune arthritis in mice
Kondo, Y., Yao, Z., Tahara, M., Iizuka, M., Yokosawa, M., Kaneko, S., Segawa, S., Tsuboi, H., Yoh, K., Takahashi, S., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0606-5 · Cited by 16
“(E) cDNA was obtained from sorted CXCR5+CD4+ T cells isolated from draining LNs on day 10 post first CII immunization, and expression levels of Bcl-6 and IL-21 were analyzed by real-time PCR. Data are representative of two independent experiments with similar results, and represent the mean ± standard error of the mea…”
BackgroundInfluentialMiteva, L. D., Stanilov, N., Cirovski, G., & Stanilova, S. A. (2017) · Cancer Microenvironment · doi:10.1007/s12307-017-0198-5 · Cited by 18
Ismail, M. B., Åkefeldt, S. O., Lourda, M., Gavhed, D., Aricò, M., Henter, J., Delprat, C., & Valentin, H. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154877 · Cited by 16
Biomarkers in asthma, potential for therapeutic intervention
Pasha, M. A., Hopp, R. J., Habib, N., & Tang, D. D. (2024) · Journal of Asthma · doi:10.1080/02770903.2024.2361783 · Cited by 18
“Possible pathogenic roles for IL-17A in the asthmatic airway include promotion of airway neutrophilia, mediation of AHR, and cortico-steroid resistance (106–109).”
Cheung, K. L., Jaganathan, A., Hu, Y., Xu, F., Lejeune, A., Sharma, R., Caescu, C. I., Meslamani, J. E., Vincek, A. S., Zhang, F., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2117112119 · Cited by 16
“Because Th17 cells have been implicated in the development of inflammatory disorders such as inflammatory bowel diseases (33, 34), we evaluated the in vivo effects of Hipk2 KO on Th17 cell development in the mouse model of T cell transfer–induced colitis (Fig.”
BackgroundHost Subcellular Organelles: Targets of Viral Manipulation
Song, M. S., Lee, D., Lee, C.-Y., Park, S., & Yang, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031638 · Cited by 17
Xiong, Y., Ma, X., He, B., Zhi, J., Liu, X., Wang, P., Zhou, Z., & Liu, D. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c09682 · Cited by 15
Program Death-1 Suppresses Autoimmune Arthritis by Inhibiting Th17 Response
Yang, L., Qiao, G., Hassan, Y., Li, Z., Zhang, X., Kong, H., Zeng, W., Yin, F., & Zhang, J. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0404-z · Cited by 15
“Although CIA was originally considered as a Th1-mediated autoimmune disease, recent studies indicate that the newly identified Th17 subset that predominantly produces interleukin (IL)-17 is the major initiator of the disease (Lubberts et al. 2004; Miossec and Kolls 2012; Wehrens et al. 2012).”
MethodResultA20 ameliorates inflammatory bowel disease in mice via inhibiting NF-κB and STAT3 activation
Lee, S. H., Lee, H.-R., Kwon, J. Y., Jung, K., Kim, S. Y., Cho, K.-H., Choi, J., Lee, H. H., Lee, B., Jue, D., et al. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.03.015 · Cited by 15
Kazama, K., OTAKE, J., Satoyoshi, T., Shiozawa, M., Sugano, N., Sato, S., Atsumi, Y., Kano, K., Murakawa, M., Maezawa, Y., et al. (2020) · In Vivo · doi:10.21873/invivo.11848 · Cited by 15
Meijer, F. A., van den Oetelaar, M. C. M., Doveston, R. G., Sampers, E. N. R., & Brunsveld, L. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00029 · Cited by 17
Maleki, M., Mahdavi, A. M., Soltani‐Zangbar, M. S., Yousefi, M., & Khabbazi, A. (2022) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2022.2112220 · Cited by 15
“important role in the development of various autoimmune and inflammatory diseases [5,6].”
BackgroundHan, Y., Zhou, Y., Li, H., Gong, Z., Liu, Z., Wang, H., Wang, B., Ye, X., & Liu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956027 · Cited by 15
Unexpected Targets and Triggers of Autoimmunity
Lee, Y., Collins, M. A., & Kuchroo, V. K. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0040-5 · Cited by 15
Multiple cells express interleukin 17 in oral squamous cell carcinoma
Avadhani, A., Parachuru, V. P. B., Milne, T. J., Seymour, G. J., & Rich, A. M. (2016) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12465 · Cited by 15
Abdollahi, E., Saghafi, N., Rezaee, S. A., Rastin, M., Jarahi, L., Clifton, V. L., & Rafatpanah, H. (2020) · Iranian Biomedical Journal · doi:10.29252/ibj.24.5.290 · Cited by 16
“It has been demonstrated that IL-17 is involved in the initiation or progression of inflammatory and autoimmune diseases and transplant rejection in humans [29,30] .”
BackgroundYi, F., Zhang, X., Zhai, K., Huang, Z., Wu, X., Wu, M., Shi, X., Pei, X., Dong, S., Wang, W., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000307 · Cited by 15
Kolios, A. G. A., & Tsokos, G. C. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-021-00588-0 · Cited by 15
NF-kB pathway is involved in microscopic colitis pathogenesis
Pisani, L. F., Tontini, G. E., Vecchi, M. L., Croci, G. A., & Pastorelli, L. (2022) · Journal of International Medical Research · doi:10.1177/03000605221080104 · Cited by 15
“However, when the Th17 response is inappropriate it can be a trigger in the pathogenesis of several immune and inflammatory diseases, such as rheumatoid arthritis, psoriasis, Sj€ ogren syndrome, IBD, multiple sclerosis and systemic lupus erythemathosus.(26,27) The expression of the C3 gene in MC mucosa can cause the e…”
BackgroundUnveiling the role of IL-17: Therapeutic insights and cardiovascular implications
Jiang, K., Xu, Y., Wang, Y., Yin, N., Huang, F., & Chen, M. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.05.001 · Cited by 14
Unraveling CCL20's role by regulating Th17 cell chemotaxis in experimental autoimmune prostatitis
Zhang, C., Xu, S., Hu, R., Liu, X., Yue, S., Li, X., Dai, B., Liang, C. Y., & Zhan, C. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18445 · Cited by 14
“5,6 IL-17A, a cytokine produced by Th17 cells, induced inflammation through mediating IL-6 production and neutrophil recruitment.”
Background
Metadata
- Authors
- Miossec, P., & Kolls, J. K.
- Affiliations
- Lyon 1 Université (FR)
- University of Pittsburgh (US)
- Corresponding author
- Miossec, Pierre
- Kolls, Jay K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-10
- Volume
- 11
- Issue
- 10
- Pages
- 763-776
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2022917731
- Cited by
- 1,414
- References
- 169
- Citations by year
- 2026: 74 · 2025: 104 · 2024: 137 · 2023: 101 · 2022: 121 · 2021: 129 · 2020: 97 · 2019: 91 · 2018: 67 · 2017: 114 · 2016: 100 · 2015: 109 · 2014: 97 · 2013: 72 · 2012: 1
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut Universitaire de France
- Institut Mérieux
- National Heart, Lung, and Blood Institute (R37HL079142)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- IL-17, Th17 cells, IL-17 inhibitors, IL-23, IL-17 receptor A, psoriasis, rheumatoid arthritis, ankylosing spondylitis, chronic inflammation, autoimmunity, biologic therapy, IL-17A
- MeSH terms
- Animals, Chronic Disease, Humans, Inflammation, Drug Delivery Systems, Interleukin-17, Receptors, Interleukin-17, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.